{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T11:07:44Z","timestamp":1781262464965,"version":"3.54.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.vaccine.2019.09.051","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T07:42:48Z","timestamp":1570174968000},"page":"7147-7154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Duration of post-vaccination humoral immunity against yellow fever in children"],"prefix":"10.1016","volume":"37","author":[{"given":"Tatiana Guimar\u00e3es","family":"de Noronha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"de Lourdes de Sousa Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Geraldo Leite Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jandira Aparecida","family":"Campos Lemos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Maria Barbosa de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olindo Assis","family":"Martins-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina","family":"Campi-Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"da Silva Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinaldo","family":"de Menezes Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Antonio","family":"Bastos Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2019.09.051_b0005","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1590\/S0037-86822003000200012","article-title":"Febre Amarela [Yellow fever]","volume":"36","author":"Vasconcelos","year":"2003","journal-title":"Rev Soc Bras Med Trop"},{"issue":"8","key":"10.1016\/j.vaccine.2019.09.051_b0010","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/trstmh\/tru092","article-title":"The whole iceberg: estimating the incidence of yellow fever virus infection from the number of severe cases","volume":"108","author":"Johansson","year":"2014","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.vaccine.2019.09.051_b0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001638","article-title":"Yellow Fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data","volume":"11","author":"Garske","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2019.09.051_b0020","unstructured":"World Health Organization. Countries with risk of yellow fever transmission and countries requiring yellow fever vaccination. https:\/\/www.who.int\/ith\/ITH_Annex_I.pdf."},{"key":"10.1016\/j.vaccine.2019.09.051_b0025","unstructured":"World Health Organization. Yellow Fever; 2019. Available at https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/yellow-fever"},{"key":"10.1016\/j.vaccine.2019.09.051_b0030","unstructured":"World Health Organization. Vaccines and vaccination against yellow fever. WHO position paper \u2013 June 2013. Weekly epidemiological record 2013; 88: 269\u201384"},{"key":"10.1016\/j.vaccine.2019.09.051_b0035","unstructured":"Minist\u00e9rio da Sa\u00fade, Secretaria de Vigil\u00e2ncia em Sa\u00fade. Boletim Epidemiol\u00f3gico. Aspectos epidemiol\u00f3gicos da febre amarela silvestre e a vigil\u00e2ncia intensificada durante per\u00edodo de monitoramento, Brasil, 2012\/2013 - Bras\u00edlia: Minist\u00e9rio da Sa\u00fade; 2014; 45(7): 1\u201310."},{"key":"10.1016\/j.vaccine.2019.09.051_b0040","unstructured":"World Health Organization. International health regulations; 2005. Available at:http:\/\/www.who.int\/ihr\/9789241596664\/en\/index.html,http:\/\/www.who.int\/ith\/updates\/20140605\/en\/."},{"issue":"3","key":"10.1016\/j.vaccine.2019.09.051_b0045","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4269\/ajtmh.13-0264","article-title":"Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years","volume":"89","author":"Gotuzzo","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2019.09.051_b0050","series-title":"Vaccines","first-page":"959","article-title":"Yellow fever vaccines","author":"Monath","year":"2008"},{"issue":"39","key":"10.1016\/j.vaccine.2019.09.051_b0055","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1016\/j.vaccine.2014.07.021","article-title":"Duration of post-vaccination immunity against yellow fever in adults","volume":"32","author":"Collaborative group for studies on yellow fever vaccines","year":"2014","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2019.09.051_b0060","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4269\/ajtmh.2005.72.189","article-title":"Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru","volume":"72","author":"Belmusto-Worn","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2019.09.051_b0065","unstructured":"Grupo Colaborativo do Programa Nacional de Imuniza\u00e7\u00f5es para o Estudo da Soroconvers\u00e3o pela Vacina contra Febre Amarela. Estudo multic\u00eantrico de soroconvers\u00e3o pela vacina contra febre amarela. In: VII Congresso Brasileiro de Sa\u00fade Coletiva. Bras\u00edlia-DF: 2003."},{"key":"10.1016\/j.vaccine.2019.09.051_b0070","unstructured":"WMA Declaration of Helsinki \u2013 Ethical Principles for Medical Research Involving Human Subjects. 64th WMA General Assembly, Fortaleza, Brazil, October 2013. https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/"},{"key":"10.1016\/j.vaccine.2019.09.051_b0075","unstructured":"Conselho Nacional de Sa\u00fade. Resolu\u00e7\u00e3o n\u00b0 466, de 12 de dezembro de 2012. http:\/\/conselho.saude.gov.br\/resolucoes\/2012\/reso466.pdf."},{"key":"10.1016\/j.vaccine.2019.09.051_b0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jim.2017.05.002","article-title":"Heparin removal by ecteola-cellulose pre-treatment enables the use of plasma samples for accurate measurement of anti-Yellow fever virus neutralizing antibodies","volume":"448","author":"Campi-Azevedo","year":"2017","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2019.09.051_b0085","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.biologicals.2012.09.005","article-title":"Evaluation of accuracy and reliability of the plaque reduction neutralization test (micro-PRNT) in detection of yellow fever virus antibodies","volume":"40","author":"Sim\u00f5es","year":"2012","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2019.09.051_b0090","doi-asserted-by":"crossref","unstructured":"Collaborative Group for Studies with Yellow Fever Vaccine. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213\/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program. Vaccine. 2007 Apr 20;25(16):3118\u201323. Epub 2007 Jan 22. PubMed PMID: 17316925.","DOI":"10.1016\/j.vaccine.2007.01.053"},{"key":"10.1016\/j.vaccine.2019.09.051_b0095","unstructured":"IBM Corp. Released 2011. IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY: IBM Corp."},{"key":"10.1016\/j.vaccine.2019.09.051_b0100","series-title":"R: A language and environment for statistical computing","author":"Development Core Team","year":"2008"},{"issue":"2","key":"10.1016\/j.vaccine.2019.09.051_b0105","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/21645515.2015.1082693","article-title":"Booster dose after 10 years is recommended following 17DD-YF primary vaccination","volume":"12","author":"Campi-Azevedo","year":"2016","journal-title":"Human Vaccines Immunother"},{"issue":"15","key":"10.1016\/j.vaccine.2019.09.051_b0110","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/j.vaccine.2005.12.055","article-title":"Neutralizing antibody response to booster vaccination with 17d yellow fever vaccine","volume":"24","author":"Hepburn","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.09.051_b0115","first-page":"93","article-title":"The duration of immunity following vac- cination with the 17D strain of yellow fever virus","volume":"37","author":"Fox","year":"1943","journal-title":"Am J Hyg"},{"key":"10.1016\/j.vaccine.2019.09.051_b0120","doi-asserted-by":"crossref","unstructured":"ANDERSON CR, GAST-GALVIS A. Immunity to yellow fever five years after vaccination. Am J Hyg. 1947 May;45(3):302\u20134. PubMed PMID: 20240017.","DOI":"10.1093\/oxfordjournals.aje.a119138"},{"issue":"5","key":"10.1016\/j.vaccine.2019.09.051_b0125","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/trstmh\/trt014","article-title":"Demographic profile of sylvatic yellow fever in Brazil from 1973 to 2008","volume":"107","author":"Camara","year":"2013","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2019.09.051_b0130","unstructured":"Minas Gerais. Secretaria de Estado de Sa\u00fade de Minas Gerais. Subsecretaria de Vigil\u00e2ncia e Prote\u00e7\u00e3o \u00e0 Sa\u00fade. Superintend\u00eancia de Vigil\u00e2ncia Epidemiol\u00f3gica, Ambiental e Sa\u00fade do Trabalhador. Boletim epidemiol\u00f3gico \u2013 20\/06\/2018; http:\/\/saude.mg.gov.br\/images\/documentos\/Boletim%20_Febre%20Amarela_21.06.2018_atualizada.pdf."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19312605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19312605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:35:49Z","timestamp":1759401349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19312605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":26,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0264410X19312605"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.051","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Duration of post-vaccination humoral immunity against yellow fever in children","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}